Risk Factors for Relapsing Remitting Multiple Sclerosis.
作者信息
Hill J, Harrison J, Palmer K
机构信息
Synthesis Economic Evaluation and Decision Science (SEEDS) group, University of Central Lancashire.
Lancashire and South Cumbria NHS Foundation Trust.
出版信息
Br J Neurosci Nurs. 2021 Jan;17(Sup1):S34-S36. doi: 10.12968/bjnn.2021.17.Sup1.S34. Epub 2021 Jan 28.
Abstract
摘要
相似文献
1
Risk Factors for Relapsing Remitting Multiple Sclerosis.复发缓解型多发性硬化症的危险因素。
Br J Neurosci Nurs. 2021 Jan;17(Sup1):S34-S36. doi: 10.12968/bjnn.2021.17.Sup1.S34. Epub 2021 Jan 28.
2
Sensorimotor function in progressive multiple sclerosis.进展性多发性硬化症中的感觉运动功能
Mult Scler J Exp Transl Clin. 2020 Aug 31;6(3):2055217320934835. doi: 10.1177/2055217320934835. eCollection 2020 Jul-Sep.
3
Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.复发缓解型多发性硬化症的定量磁化传递成像：系统评价与荟萃分析。
Brain Commun. 2022 Apr 4;4(2):fcac088. doi: 10.1093/braincomms/fcac088. eCollection 2022.
4
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症患者接受那他珠单抗治疗第一年期间的白质扩散变化
AJNR Am J Neuroradiol. 2016 Jun;37(6):1030-7. doi: 10.3174/ajnr.A4690. Epub 2016 Mar 10.
5
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史：一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
6
"Always looking for a new balance": toward an understanding of what it takes to continue working while being diagnosed with relapsing-remitting multiple sclerosis.“始终寻求新的平衡”：旨在理解被诊断为复发缓解型多发性硬化症后仍继续工作所需的条件。
Disabil Rehabil. 2018 Oct;40(21):2545-2552. doi: 10.1080/09638288.2017.1342278. Epub 2017 Jun 22.
7
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.miR-326 和 miR-26a 是两种潜在的多发性硬化症缓解复发期诊断标志物。
Gene. 2014 Jul 10;544(2):128-33. doi: 10.1016/j.gene.2014.04.069. Epub 2014 Apr 30.
8
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone.米托蒽醌治疗复发缓解型和快速进展型多发性硬化症：米托蒽醌治疗后十年的临床结果
Mult Scler Relat Disord. 2020 Sep;44:102330. doi: 10.1016/j.msard.2020.102330. Epub 2020 Jun 23.
9
Contribution of new and chronic cortical lesions to disability accrual in multiple sclerosis.新的和慢性皮质病变对多发性硬化症残疾累积的影响。
Brain Commun. 2024 May 2;6(3):fcae158. doi: 10.1093/braincomms/fcae158. eCollection 2024.
10
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis.组织因子作为复发性缓解型多发性硬化症的潜在凝血/血管标志物。
Front Immunol. 2023 Jul 31;14:1226616. doi: 10.3389/fimmu.2023.1226616. eCollection 2023.
本文引用的文献
1
Factors associated with relapses in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.复发缓解型多发性硬化症复发的相关因素：一项系统综述和荟萃分析。
Medicine (Baltimore). 2020 Jul 2;99(27):e20885. doi: 10.1097/MD.0000000000020885.
2
Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家多发性硬化症负担 1990-2016 年：2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Mar;18(3):269-285. doi: 10.1016/S1474-4422(18)30443-5. Epub 2019 Jan 21.
3
Multiple Sclerosis.多发性硬化症
N Engl J Med. 2018 Jan 11;378(2):169-180. doi: 10.1056/NEJMra1401483.
4
Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.多发性硬化症：发病机制、症状、诊断及基于细胞的治疗
Cell J. 2017 Apr-Jun;19(1):1-10. doi: 10.22074/cellj.2016.4867. Epub 2016 Dec 21.
5
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.与多发性硬化症的发病、复发或进展相关的因素：系统评价。
Neurotoxicology. 2017 Jul;61:189-212. doi: 10.1016/j.neuro.2016.03.020. Epub 2016 Apr 1.
6
Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review.复发缓解型和原发进展型多发性硬化症发病相关的危险因素：一项系统综述。
Biomed Res Int. 2015;2015:817238. doi: 10.1155/2015/817238. Epub 2015 Jan 31.
7
Multiple sclerosis: pathogenesis and treatment.多发性硬化症：发病机制与治疗。
Curr Neuropharmacol. 2011 Sep;9(3):409-16. doi: 10.2174/157015911796557911.
8
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.多发性硬化症的诊断标准：2010 年麦克唐纳标准修订版。
Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366.
9
Modifiable factors influencing relapses and disability in multiple sclerosis.影响多发性硬化症复发和残疾的可改变因素。
Mult Scler. 2010 Jul;16(7):773-85. doi: 10.1177/1352458510367721. Epub 2010 May 18.
10
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.多发性硬化症的新诊断标准：研究方案指南。
Ann Neurol. 1983 Mar;13(3):227-31. doi: 10.1002/ana.410130302.
Zotero 插件